AKYA - יתרת חוב לטווח ארוך akoyabio.com

The price indicator on the Akoya Biosciences (AKYA) chart reflects the dynamics of a company whose spatial biology system development capacities are based in the US at the level of 0.00. Significant operating expenses and inertia within the medical community are constraining growth rates. However, patents and high switching costs create a robust barrier to entry for new players, ensuring a sustainable competitive advantage.

Asset reliability is determined by the balance between expansion and debt load. This indicator aggregates all credit obligations with maturities exceeding one year, measuring the pressure of interest payments on net income. For Akoya Biosciences (AKYA), such loans finance the development of spatial tissue analysis systems. Stable revenue from reagent sales must cover these costs. An analysis of the company's long-term financial obligations allows for an assessment of its leverage sustainability.